These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 7624960)

  • 1. A human model of xenogeneic graft-versus-host disease in SCID mice engrafted with human peripheral blood lymphocytes.
    Sandhu JS; Gorczynski R; Shpitz B; Gallinger S; Nguyen HP; Hozumi N
    Transplantation; 1995 Jul; 60(2):179-84. PubMed ID: 7624960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of HPV16 positive cervical cancer model in the hu-PBL-SCID mouse and its immunological features].
    Liang ZX; Cheng Q; Chen HZ; Xie X; Ye DF
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1465-9. PubMed ID: 15500747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
    Boyle MJ; Connors M; Flanigan ME; Geiger SP; Ford H; Baseler M; Adelsberger J; Davey RT; Lane HC
    J Immunol; 1995 Jun; 154(12):6612-23. PubMed ID: 7759895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Establishment of an xenogeneic acute graft-versus-host disease model in NOD/SCID mice by engraftment of G-CSF mobilized human mononuclear cells].
    Gao L; Wang JM; Xie LN; Zhou H; Qiu HY
    Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):87-91. PubMed ID: 18681307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The fate of human peripheral blood lymphocytes after transplantation into SCID mice.
    Martino G; Anastasi J; Feng J; Mc Shan C; DeGroot L; Quintans J; Grimaldi LM
    Eur J Immunol; 1993 May; 23(5):1023-8. PubMed ID: 8477797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific antibody production to a recall or a neoantigen by SCID mice reconstituted with human peripheral blood lymphocytes.
    Nonoyama S; Smith FO; Ochs HD
    J Immunol; 1993 Oct; 151(7):3894-901. PubMed ID: 8376809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Human peripheral blood CD4+ T-lymphocytes reconstituting severe combined immunodeficient mouse-human cell immune system and its immunological function].
    Zeng QH; Wang W; Liu T; Shi Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):513-6. PubMed ID: 16137035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection.
    Shiroki R; Poindexter NJ; Woodle ES; Hussain MS; Mohanakumar T; Scharp DW
    Transplantation; 1994 Jun; 57(11):1555-62. PubMed ID: 8009588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts.
    Alegre ML; Peterson LJ; Jeyarajah DR; Weiser M; Bluestone JA; Thistlethwaite JR
    J Immunol; 1994 Sep; 153(6):2738-49. PubMed ID: 8077678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary Th1 cell immunization against HIVgp160 in SCID-hu mice coengrafted with peripheral blood lymphocytes and skin.
    Delhem N; Hadida F; Gorochov G; Carpentier F; de Cavel JP; Andréani JF; Autran B; Cesbron JY
    J Immunol; 1998 Aug; 161(4):2060-9. PubMed ID: 9712080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
    Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
    Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xenogeneic PBL-scid mice: their potential and current limitations.
    Greenwood JD
    Lab Anim Sci; 1993 Apr; 43(2):151-5. PubMed ID: 8320963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneal sanctuary for human lymphopoiesis in SCID mice injected with human peripheral blood lymphocytes from Epstein-Barr virus-negative donors.
    Hoffmann-Fezer G; Kranz B; Gall C; Thierfelder S
    Eur J Immunol; 1992 Dec; 22(12):3161-6. PubMed ID: 1359971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute human vs. mouse graft vs. host disease in normal and immunodeficient mice.
    Huppes W; De Geus B; Zurcher C; Van Bekkum DW
    Eur J Immunol; 1992 Jan; 22(1):197-206. PubMed ID: 1730249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human-mouse lymphoid chimeras: host-vs.-graft and graft-vs.-host reactions.
    Murphy WJ; Bennett M; Anver MR; Baseler M; Longo DL
    Eur J Immunol; 1992 Jun; 22(6):1421-7. PubMed ID: 1534757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human primary immune response in SCID mice engrafted with human peripheral blood lymphocytes.
    Sandhu J; Shpitz B; Gallinger S; Hozumi N
    J Immunol; 1994 Apr; 152(8):3806-13. PubMed ID: 8144950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human peripheral blood leukocyte engraftment into SCID mice: critical role of CD4(+) T cells.
    Duchosal MA; Mauray S; Rüegg M; Trouillet P; Vallet V; Aarden L; Tissot JD; Schapira M
    Cell Immunol; 2001 Jul; 211(1):8-20. PubMed ID: 11585383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of SCID mice in biotechnology and as a model for human disease.
    Sandhu JS; Boynton E; Gorczynski R; Hozumi N
    Crit Rev Biotechnol; 1996; 16(1):95-118. PubMed ID: 8935910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engraftment and activity of anti-CD3-activated human peripheral blood lymphocytes transferred into mice with severe combined immune deficiency.
    Murphy WJ; Conlon KC; Sayers TJ; Wiltrout RH; Back TC; Ortaldo JR; Longo DL
    J Immunol; 1993 Apr; 150(8 Pt 1):3634-42. PubMed ID: 8468492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.